Zangerle R - Search Results

1

Human immunodeficiency virus type 1 protease inhibitor attenuates Candida albicans virulence properties in vitro.

Gruber A, Speth C, Lukasser-Vogl E, Zangerle R, Borg-von Zepelin M, Dierich MP, Würzner R. Gruber A, et al. Among authors: zangerle r. Immunopharmacology. 1999 Apr;41(3):227-34. doi: 10.1016/s0162-3109(99)00035-1. Immunopharmacology. 1999. PMID: 10428651

2

In vitro susceptibility of Candida albicans, Austria 1992.

Allerberger F, Fassl A, Niederwieser D, Zangerle R, Lingnau W, Dierich MP. Allerberger F, et al. Among authors: zangerle r. Mycoses. 1993 Nov-Dec;36(11-12):411-6. doi: 10.1111/j.1439-0507.1993.tb00730.x. Mycoses. 1993. PMID: 7935573

3

Comparison of Western blot (immunoblot) based on recombinant-derived p41 with conventional tests for serodiagnosis of human immunodeficiency virus infections.

Hofbauer JM, Schulz TF, Hengster P, Larcher C, Zangerle R, Kofler H, Fritsch P, Wachter H, Dierich MP. Hofbauer JM, et al. Among authors: zangerle r. J Clin Microbiol. 1988 Jan;26(1):116-20. doi: 10.1128/jcm.26.1.116-120.1988. J Clin Microbiol. 1988. PMID: 3277988 Free PMC article.

4

Sera from HIV-1 infected individuals in all stages of disease preferentially recognize the V3 loop of the prototypic macrophage-tropic glycoprotein gp120 ADA.

Ebenbichler C, McNearney T, Stoiber H, Möst J, Zangerle R, Vogetseder W, Patsch JR, Ratner L, Dierich MP. Ebenbichler C, et al. Among authors: zangerle r. Mol Immunol. 1995 Oct;32(14-15):1039-45. doi: 10.1016/0161-5890(95)00083-6. Mol Immunol. 1995. PMID: 8544853

5

Longitudinal study of antibody reactivity against HIV-1 envelope and a peptide representing a conserved site on Gp41 in HIV-1-infected patients.

Mühlbacher M, Spruth M, Siegel F, Zangerle R, Dierich MP. Mühlbacher M, et al. Among authors: zangerle r. Immunobiology. 1999 Jun;200(2):295-305. doi: 10.1016/s0171-2985(99)80078-3. Immunobiology. 1999. PMID: 10416136

6

High risk of developing toxoplasmic encephalitis in AIDS patients seropositive to Toxoplasma gondii.

Zangerle R, Allerberger F, Pohl P, Fritsch P, Dierich MP. Zangerle R, et al. Med Microbiol Immunol. 1991;180(2):59-66. doi: 10.1007/BF00193846. Med Microbiol Immunol. 1991. PMID: 1881367

7

Increased concentrations of soluble tumor necrosis factor receptor 75 but not of soluble intercellular adhesion molecule-1 are associated with the decline of CD4+ lymphocytes in HIV infection.

Zangerle R, Fuchs D, Sarcletti M, Gallati H, Reibnegger G, Wachter H, Dierich MP, Möst J. Zangerle R, et al. Clin Immunol Immunopathol. 1994 Sep;72(3):328-34. doi: 10.1006/clin.1994.1149. Clin Immunol Immunopathol. 1994. PMID: 7914841

8

Neopterin and HIV infection.

Fuchs D, Zangerle R, Murr C, Dierich MP, Wachter H. Fuchs D, et al. Among authors: zangerle r. Acta Microbiol Immunol Hung. 1994;41 Suppl:21-5. Acta Microbiol Immunol Hung. 1994. PMID: 8075943 No abstract available.

9

Elevated concentrations of circulating intercellular adhesion molecule 1 (ICAM-1) in HIV-1 infection.

Möst J, Zangerle R, Herold M, Fuchs D, Wachter H, Fritsch P, Dierich MP. Möst J, et al. Among authors: zangerle r. J Acquir Immune Defic Syndr (1988). 1993 Mar;6(3):221-6. J Acquir Immune Defic Syndr (1988). 1993. PMID: 8095541

10

Association between immune activation, changes of iron metabolism and anaemia in patients with HIV infection.

Fuchs D, Zangerle R, Artner-Dworzak E, Weiss G, Fritsch P, Tilz GP, Dierich MP, Wachter H. Fuchs D, et al. Among authors: zangerle r. Eur J Haematol. 1993 Feb;50(2):90-4. doi: 10.1111/j.1600-0609.1993.tb00147.x. Eur J Haematol. 1993. PMID: 8440363

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

256 results

Search Page

Filters